Table 5.

Smoking prevalence and treatment in cancer clinics by use of the ELEVATE module.

	Module		No Module
	N	%	N	%	Diff.	95% CI	Chi-sq	p
Total Patients *	31,026		10,188
Assessment	26,350	84.9	9170	90.0	−5.1	−5.8, −4.4	165.7	<0.0001
Smoking **	3445	13.1	952	10.4	2.7	1.9, 3.4	45.1	<0.0001
Total Smokers	3445		952
Any Treatment ***	1076	31.2	167	17.5	13.7	10.8, 16.6	68.3	<0.0001
Brief Advice	844	24.5	139	14.6	9.9	7.2, 12.6	41.5	<0.0001
Medication	234	6.8	34	3.6	3.2	1.7, 4.7	13.0	0.00032
Additional Counseling Offer	847	24.6	9	0.95	23.6	22.0, 25.3	264.4	<0.0001
Additional Counseling Referral ****	100	2.9	0	0.0	2.9	2.3, 3.5	27.0	<0.0001

* Out of 31,026 patients who visited cancer clinics that used the module, 29,854 patients (97.2%) only visited urban cancer clinics, 1,114 patients (3.6%) only visited rural cancer clinics, and 58 patients (0.2%) visited both urban and rural cancer clinics. There were no cancer clinics that did not use the module at rural location in this sample. ** For patients without smoking status assessment, if they received any smoking cessation treatment, they would be identified as smokers. Therefore, smoking prevalence in cancer clinics that used the module and cancer clinics that did not use the module were calculated for patients who were assessed and documented as smokers or received any type of smoking cessation treatment (n = 26,372 and 9,176). *** Any treatment is defined as patients receiving medication, brief advice given, or additional counseling was referred. **** For clinics with the module, additional counseling referral (n = 100) consisted of engagement in Quitline referral (n = 49), QuitGuide or QuitStart app (n = 5), SmokefreeTXT (n = 17), Quitline and SmokefreeTXT (n = 3), and already referred at time of visit (n = 26). For clinics without the module, no patients received additional counseling referral.